Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 15 |
NetGPI | no | yes: 0, no: 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005789 | endoplasmic reticulum membrane | 4 | 3 |
GO:0016020 | membrane | 2 | 16 |
GO:0031090 | organelle membrane | 3 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 16 |
Related structures:
AlphaFold database: Q4QAA5
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 16 |
GO:0006629 | lipid metabolic process | 3 | 16 |
GO:0006631 | fatty acid metabolic process | 4 | 16 |
GO:0006633 | fatty acid biosynthetic process | 5 | 16 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 6 | 16 |
GO:0008152 | metabolic process | 1 | 16 |
GO:0008610 | lipid biosynthetic process | 4 | 16 |
GO:0009058 | biosynthetic process | 2 | 16 |
GO:0009987 | cellular process | 1 | 16 |
GO:0016053 | organic acid biosynthetic process | 4 | 16 |
GO:0019752 | carboxylic acid metabolic process | 5 | 16 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 16 |
GO:0033559 | unsaturated fatty acid metabolic process | 5 | 16 |
GO:0043436 | oxoacid metabolic process | 4 | 16 |
GO:0044237 | cellular metabolic process | 2 | 16 |
GO:0044238 | primary metabolic process | 2 | 16 |
GO:0044249 | cellular biosynthetic process | 3 | 16 |
GO:0044255 | cellular lipid metabolic process | 3 | 16 |
GO:0044281 | small molecule metabolic process | 2 | 16 |
GO:0044283 | small molecule biosynthetic process | 3 | 16 |
GO:0046394 | carboxylic acid biosynthetic process | 5 | 16 |
GO:0071704 | organic substance metabolic process | 2 | 16 |
GO:0072330 | monocarboxylic acid biosynthetic process | 6 | 16 |
GO:1901576 | organic substance biosynthetic process | 3 | 16 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 16 |
GO:0004768 | stearoyl-CoA 9-desaturase activity | 6 | 16 |
GO:0005488 | binding | 1 | 7 |
GO:0005506 | iron ion binding | 6 | 3 |
GO:0016215 | acyl-CoA desaturase activity | 5 | 16 |
GO:0016491 | oxidoreductase activity | 2 | 16 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3 | 16 |
GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water | 4 | 16 |
GO:0043167 | ion binding | 2 | 7 |
GO:0043169 | cation binding | 3 | 7 |
GO:0046872 | metal ion binding | 4 | 7 |
GO:0046914 | transition metal ion binding | 5 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 320 | 324 | PF00656 | 0.482 |
CLV_NRD_NRD_1 | 334 | 336 | PF00675 | 0.364 |
CLV_NRD_NRD_1 | 368 | 370 | PF00675 | 0.341 |
CLV_NRD_NRD_1 | 37 | 39 | PF00675 | 0.409 |
CLV_PCSK_KEX2_1 | 37 | 39 | PF00082 | 0.418 |
CLV_PCSK_SKI1_1 | 192 | 196 | PF00082 | 0.201 |
CLV_PCSK_SKI1_1 | 228 | 232 | PF00082 | 0.300 |
CLV_PCSK_SKI1_1 | 29 | 33 | PF00082 | 0.484 |
CLV_PCSK_SKI1_1 | 328 | 332 | PF00082 | 0.324 |
CLV_PCSK_SKI1_1 | 369 | 373 | PF00082 | 0.308 |
CLV_PCSK_SKI1_1 | 417 | 421 | PF00082 | 0.269 |
CLV_PCSK_SKI1_1 | 442 | 446 | PF00082 | 0.214 |
CLV_PCSK_SKI1_1 | 447 | 451 | PF00082 | 0.340 |
DEG_Nend_UBRbox_4 | 1 | 3 | PF02207 | 0.329 |
DOC_CKS1_1 | 315 | 320 | PF01111 | 0.492 |
DOC_CYCLIN_RxL_1 | 325 | 334 | PF00134 | 0.592 |
DOC_MAPK_MEF2A_6 | 344 | 352 | PF00069 | 0.594 |
DOC_PP1_RVXF_1 | 226 | 232 | PF00149 | 0.244 |
DOC_PP1_RVXF_1 | 301 | 308 | PF00149 | 0.448 |
DOC_PP1_RVXF_1 | 394 | 401 | PF00149 | 0.553 |
DOC_PP2B_LxvP_1 | 348 | 351 | PF13499 | 0.566 |
DOC_PP2B_LxvP_1 | 57 | 60 | PF13499 | 0.267 |
DOC_USP7_MATH_1 | 433 | 437 | PF00917 | 0.375 |
DOC_USP7_UBL2_3 | 192 | 196 | PF12436 | 0.481 |
DOC_USP7_UBL2_3 | 328 | 332 | PF12436 | 0.508 |
DOC_WW_Pin1_4 | 314 | 319 | PF00397 | 0.472 |
LIG_14-3-3_CanoR_1 | 100 | 107 | PF00244 | 0.458 |
LIG_14-3-3_CanoR_1 | 257 | 265 | PF00244 | 0.457 |
LIG_14-3-3_CanoR_1 | 303 | 308 | PF00244 | 0.579 |
LIG_14-3-3_CanoR_1 | 369 | 374 | PF00244 | 0.442 |
LIG_Actin_WH2_2 | 434 | 449 | PF00022 | 0.497 |
LIG_BRCT_BRCA1_1 | 109 | 113 | PF00533 | 0.497 |
LIG_deltaCOP1_diTrp_1 | 216 | 222 | PF00928 | 0.254 |
LIG_deltaCOP1_diTrp_1 | 354 | 358 | PF00928 | 0.524 |
LIG_FHA_1 | 234 | 240 | PF00498 | 0.261 |
LIG_FHA_1 | 296 | 302 | PF00498 | 0.434 |
LIG_FHA_1 | 422 | 428 | PF00498 | 0.454 |
LIG_FHA_1 | 79 | 85 | PF00498 | 0.270 |
LIG_FHA_2 | 143 | 149 | PF00498 | 0.441 |
LIG_FHA_2 | 20 | 26 | PF00498 | 0.394 |
LIG_FHA_2 | 268 | 274 | PF00498 | 0.435 |
LIG_FHA_2 | 315 | 321 | PF00498 | 0.501 |
LIG_FHA_2 | 341 | 347 | PF00498 | 0.566 |
LIG_FHA_2 | 39 | 45 | PF00498 | 0.540 |
LIG_LIR_Gen_1 | 110 | 120 | PF02991 | 0.488 |
LIG_LIR_Gen_1 | 169 | 178 | PF02991 | 0.463 |
LIG_LIR_Gen_1 | 180 | 189 | PF02991 | 0.399 |
LIG_LIR_Gen_1 | 245 | 254 | PF02991 | 0.405 |
LIG_LIR_Gen_1 | 273 | 283 | PF02991 | 0.433 |
LIG_LIR_Gen_1 | 323 | 331 | PF02991 | 0.549 |
LIG_LIR_Gen_1 | 355 | 366 | PF02991 | 0.524 |
LIG_LIR_Gen_1 | 48 | 59 | PF02991 | 0.418 |
LIG_LIR_Gen_1 | 95 | 102 | PF02991 | 0.296 |
LIG_LIR_Nem_3 | 110 | 116 | PF02991 | 0.501 |
LIG_LIR_Nem_3 | 12 | 18 | PF02991 | 0.248 |
LIG_LIR_Nem_3 | 169 | 173 | PF02991 | 0.463 |
LIG_LIR_Nem_3 | 180 | 186 | PF02991 | 0.399 |
LIG_LIR_Nem_3 | 245 | 251 | PF02991 | 0.438 |
LIG_LIR_Nem_3 | 273 | 278 | PF02991 | 0.433 |
LIG_LIR_Nem_3 | 355 | 361 | PF02991 | 0.508 |
LIG_LIR_Nem_3 | 48 | 54 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 95 | 101 | PF02991 | 0.316 |
LIG_PCNA_yPIPBox_3 | 369 | 382 | PF02747 | 0.538 |
LIG_Pex14_1 | 115 | 119 | PF04695 | 0.454 |
LIG_Pex14_1 | 217 | 221 | PF04695 | 0.241 |
LIG_Pex14_2 | 278 | 282 | PF04695 | 0.413 |
LIG_REV1ctd_RIR_1 | 192 | 200 | PF16727 | 0.414 |
LIG_SH2_CRK | 170 | 174 | PF00017 | 0.465 |
LIG_SH2_CRK | 183 | 187 | PF00017 | 0.447 |
LIG_SH2_CRK | 223 | 227 | PF00017 | 0.228 |
LIG_SH2_CRK | 98 | 102 | PF00017 | 0.454 |
LIG_SH2_GRB2like | 275 | 278 | PF00017 | 0.441 |
LIG_SH2_PTP2 | 51 | 54 | PF00017 | 0.360 |
LIG_SH2_SRC | 42 | 45 | PF00017 | 0.596 |
LIG_SH2_SRC | 428 | 431 | PF00017 | 0.405 |
LIG_SH2_SRC | 437 | 440 | PF00017 | 0.375 |
LIG_SH2_STAP1 | 223 | 227 | PF00017 | 0.244 |
LIG_SH2_STAP1 | 47 | 51 | PF00017 | 0.459 |
LIG_SH2_STAT3 | 150 | 153 | PF00017 | 0.425 |
LIG_SH2_STAT3 | 185 | 188 | PF00017 | 0.425 |
LIG_SH2_STAT5 | 107 | 110 | PF00017 | 0.472 |
LIG_SH2_STAT5 | 142 | 145 | PF00017 | 0.446 |
LIG_SH2_STAT5 | 185 | 188 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 221 | 224 | PF00017 | 0.228 |
LIG_SH2_STAT5 | 391 | 394 | PF00017 | 0.564 |
LIG_SH2_STAT5 | 437 | 440 | PF00017 | 0.510 |
LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.360 |
LIG_SH3_3 | 200 | 206 | PF00018 | 0.300 |
LIG_SH3_3 | 312 | 318 | PF00018 | 0.487 |
LIG_SUMO_SIM_anti_2 | 377 | 384 | PF11976 | 0.542 |
LIG_TRAF2_1 | 41 | 44 | PF00917 | 0.565 |
LIG_TYR_ITIM | 49 | 54 | PF00017 | 0.497 |
LIG_TYR_ITIM | 96 | 101 | PF00017 | 0.266 |
LIG_UBA3_1 | 17 | 26 | PF00899 | 0.161 |
LIG_UBA3_1 | 410 | 417 | PF00899 | 0.454 |
LIG_WRC_WIRS_1 | 268 | 273 | PF05994 | 0.414 |
MOD_CK1_1 | 103 | 109 | PF00069 | 0.454 |
MOD_CK1_1 | 260 | 266 | PF00069 | 0.414 |
MOD_CK1_1 | 384 | 390 | PF00069 | 0.531 |
MOD_CK1_1 | 421 | 427 | PF00069 | 0.470 |
MOD_CK2_1 | 19 | 25 | PF00069 | 0.315 |
MOD_CK2_1 | 267 | 273 | PF00069 | 0.405 |
MOD_CK2_1 | 38 | 44 | PF00069 | 0.579 |
MOD_CK2_1 | 433 | 439 | PF00069 | 0.443 |
MOD_CMANNOS | 214 | 217 | PF00535 | 0.426 |
MOD_Cter_Amidation | 367 | 370 | PF01082 | 0.346 |
MOD_GlcNHglycan | 126 | 130 | PF01048 | 0.227 |
MOD_GlcNHglycan | 200 | 203 | PF01048 | 0.228 |
MOD_GlcNHglycan | 420 | 423 | PF01048 | 0.234 |
MOD_GSK3_1 | 103 | 110 | PF00069 | 0.472 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.340 |
MOD_GSK3_1 | 238 | 245 | PF00069 | 0.309 |
MOD_GSK3_1 | 252 | 259 | PF00069 | 0.419 |
MOD_GSK3_1 | 350 | 357 | PF00069 | 0.513 |
MOD_GSK3_1 | 417 | 424 | PF00069 | 0.463 |
MOD_N-GLC_1 | 252 | 257 | PF02516 | 0.225 |
MOD_N-GLC_2 | 89 | 91 | PF02516 | 0.360 |
MOD_NEK2_1 | 125 | 130 | PF00069 | 0.448 |
MOD_NEK2_1 | 156 | 161 | PF00069 | 0.441 |
MOD_NEK2_1 | 17 | 22 | PF00069 | 0.205 |
MOD_NEK2_1 | 238 | 243 | PF00069 | 0.303 |
MOD_NEK2_1 | 331 | 336 | PF00069 | 0.600 |
MOD_NEK2_1 | 381 | 386 | PF00069 | 0.568 |
MOD_NEK2_1 | 92 | 97 | PF00069 | 0.358 |
MOD_PIKK_1 | 3 | 9 | PF00454 | 0.444 |
MOD_PKA_1 | 369 | 375 | PF00069 | 0.447 |
MOD_PKA_2 | 256 | 262 | PF00069 | 0.430 |
MOD_Plk_1 | 168 | 174 | PF00069 | 0.512 |
MOD_Plk_1 | 354 | 360 | PF00069 | 0.522 |
MOD_Plk_2-3 | 354 | 360 | PF00069 | 0.441 |
MOD_Plk_4 | 168 | 174 | PF00069 | 0.503 |
MOD_Plk_4 | 204 | 210 | PF00069 | 0.228 |
MOD_Plk_4 | 233 | 239 | PF00069 | 0.244 |
MOD_Plk_4 | 260 | 266 | PF00069 | 0.446 |
MOD_Plk_4 | 303 | 309 | PF00069 | 0.569 |
MOD_Plk_4 | 369 | 375 | PF00069 | 0.472 |
MOD_Plk_4 | 433 | 439 | PF00069 | 0.438 |
MOD_Plk_4 | 75 | 81 | PF00069 | 0.205 |
MOD_ProDKin_1 | 314 | 320 | PF00069 | 0.474 |
TRG_ENDOCYTIC_2 | 170 | 173 | PF00928 | 0.482 |
TRG_ENDOCYTIC_2 | 183 | 186 | PF00928 | 0.400 |
TRG_ENDOCYTIC_2 | 223 | 226 | PF00928 | 0.228 |
TRG_ENDOCYTIC_2 | 275 | 278 | PF00928 | 0.427 |
TRG_ENDOCYTIC_2 | 51 | 54 | PF00928 | 0.407 |
TRG_ENDOCYTIC_2 | 98 | 101 | PF00928 | 0.441 |
TRG_NES_CRM1_1 | 320 | 333 | PF08389 | 0.426 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCI5 | Leptomonas seymouri | 83% | 100% |
A0A0S4KNP4 | Bodo saltans | 59% | 100% |
A0A1X0NW01 | Trypanosomatidae | 64% | 100% |
A0A3Q8I9W7 | Leishmania donovani | 44% | 97% |
A0A3Q8IBJ0 | Leishmania donovani | 97% | 100% |
A0A3R7MEL0 | Trypanosoma rangeli | 65% | 100% |
A4H6I1 | Leishmania braziliensis | 45% | 98% |
A4HDT6 | Leishmania braziliensis | 92% | 100% |
A4HVZ3 | Leishmania infantum | 44% | 97% |
A4I134 | Leishmania infantum | 97% | 100% |
B7SB91 | Acheta domesticus | 28% | 100% |
C9ZW73 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 62% | 100% |
E9APP5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 46% | 99% |
E9AX71 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
G5ED44 | Caenorhabditis elegans | 31% | 100% |
G5EGH6 | Caenorhabditis elegans | 32% | 100% |
O02858 | Sus scrofa | 28% | 100% |
O44390 | Trichoplusia ni | 31% | 100% |
O65797 | Arabidopsis thaliana | 27% | 100% |
O94523 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 41% | 94% |
P07308 | Rattus norvegicus | 28% | 100% |
P13516 | Mus musculus | 28% | 100% |
P21147 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 39% | 88% |
Q12618 | Ajellomyces capsulatus | 39% | 95% |
Q4QFT4 | Leishmania major | 45% | 97% |
Q9LVZ3 | Arabidopsis thaliana | 27% | 100% |
Q9SID2 | Arabidopsis thaliana | 30% | 100% |